- Home
- Supplements
- PQQ
- Antioxidant Protection
PQQ for Antioxidant Protection
PQQ is a redox cofactor with strong laboratory antioxidant credentials and minimal human data.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- Studied at 20 mg/day; antioxidant outcomes in humans have not been demonstrated
- Expected timeframe
- Not established
Protocol
- form
- Pyrroloquinoline quinone disodium salt (BioPQQ was used in most trials)
- duration
- Trials ran 8-12 weeks
- co factor
- Evidence is insufficient. PQQ is a genuinely interesting redox cofactor - it can undergo thousands of catalytic redox cycles compared with a few for ascorbate, which is the origin of claims about its antioxidant potency, and in vitro and rodent studies show it reduces oxidative stress markers and protects mitochondria. Human data are sparse: a small study by Harris and colleagues in ten subjects at 0.2 mg/kg reported changes in urinary metabolites and reduced plasma C-reactive protein and IL-6, but this was uncontrolled and tiny. No adequately powered randomised trial has shown meaningful antioxidant effects in humans at the 20 mg/day dose typically sold.
- titration
- Not applicable - no dose has been shown to produce a clinically meaningful antioxidant effect in people
- starting dose
- Not established for this outcome. Human trials used 20 mg/day of PQQ disodium salt, occasionally 40 mg/day
Evidence
What the studies say
Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects
Harris CB, Chowanadisai W, Mishchuk DO +3 more
PQQ 0.3 mg/kg/day reduced plasma CRP and IL-6 and shifted urinary metabolites consistent with enhanced mitochondrial-related metabolism.
Safety
Caveats
Antioxidant capacity in a test tube does not predict health benefit, and this is one of the better-established lessons in nutrition research - large trials of beta-carotene, vitamin E and vitamin C at supplemental doses found no benefit and in some cases harm, with beta-carotene increasing lung cancer in smokers. Reactive oxygen species also have necessary signalling roles, including in exercise adaptation, so blanket suppression is not desirable. Safety of PQQ: human trials are short and small, so the long-term safety profile is genuinely unknown - this is a compound with a thin safety database rather than an established one. Reported side effects at 20-40 mg/day include headache, fatigue and sleep disturbance. A rodent study found kidney effects at very high doses, and there is no established upper limit for humans, so doses above the 20 mg/day studied should be avoided. Avoid in pregnancy and breastfeeding, as no safety data exist. No significant drug interactions are documented, but the absence of data is not the same as the absence of risk, and anyone on medication should discuss it. If oxidative stress is the concern, a diet rich in vegetables, fruit, legumes and whole grains has the evidence that isolated antioxidant supplements lack.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.